Activist 13D/13G Filings - NEXTECH VI ONCOLOGY SCSP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:35 pm
Unchanged
13GARS Pharmaceuticals Inc.
SPRY
NEXTECH VI ONCOLOGY SCSP1,910,029
2%
0
(Unchanged)
View
2021-09-27
4:36 pm
Purchase
13GTyra Biosciences Inc.
TYRA
NEXTECH VI ONCOLOGY SCSP2,518,582
5.9%
2,518,582increase
(New Position)
View
2021-02-16
4:01 pm
Purchase
13GARS Pharmaceuticals Inc.
SPRY
NEXTECH VI ONCOLOGY SCSP1,910,029
5.5%
1,910,029increase
(New Position)
View